
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, David S. Boyer, MD, discusses the progress of two phase 3 clinical trials for OPT-302 in combination with either ranibizumab or aflibercept.
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, David S. Boyer, MD, discusses the progress of two phase 3 clinical trials for OPT-302 in combination with either ranibizumab or aflibercept.
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, David S. Boyer, MD, discusses the progress of two phase 3 clinical trials for OPT-302 in combination with either ranibizumab or aflibercept.